发明名称 |
PHARMACEUTICAL COMPOSTION FOR THE TREATMENT OF ADAM17 SUBSTRATE DEPENDANT CANCERS |
摘要 |
The present disclosure relates to the treatment of cancers and, more particularly, to the treatment of ADAM17 substrate dependant cancers which are refractory. The pharmaceutical composition contains an ADAM17 antibody (it recognizes an epitope within the membrane proximal domain of ADAM17 localized between the residues 564 and 642) characterized by the sequences of its variable chains. |
申请公布号 |
WO2016102715(A1) |
申请公布日期 |
2016.06.30 |
申请号 |
WO2016EP50028 |
申请日期 |
2016.01.04 |
申请人 |
PIERRE FABRE MEDICAMENT |
发明人 |
LOWE, PETER;BOUTE, NICOLAS;JOUHANNEAUD, ALEXANDRA |
分类号 |
A61K39/395;A61K39/00;A61P35/00;C07K16/28;C07K16/40 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|